ACCENT® CE
This activity is eligible for up to 15.5 ACCENT continuing education credits.
Activity ID# 4290. This activity was planned in accordance with ACCENT Guidelines.
At the conclusion of this activity, participants will be sent instructions to complete a brief evaluation and claim credit. Contact education@myadlm.org with any questions.
CME
Attendees of the ACS Annual Meeting in Jacksonville wishing to claim ACCENT credits for their attendance should email the ACS Executive Director, Dr. Charles Hawker, Charlie@charlesdhawker.com, who will reply with the CE link for the activity.
- Attendees must have an ADLM (formerly AACC) account.
- How to process claims: When your attendees follow the CE Link, they will be asked to 1) sign in to their ADLM account, 2) confirm their demographic information, 3) evaluate the speaker(s) and the activity for their quality, 4) submit their evaluation and select “ACCENT Verification of Participation Certificate.” Once selected, a printable/savable pdf of their credit certificate will be provided in a pop-up window.
- If attendees have any difficulties with the process, please contact Charles Hawker at the above email address. Only when an attendee has a technical concern with the CE Link, should the inquiry be sent to Education@myadlm.org.
- Credit for this activity must be claimed by April 30, 2025.
As a result of participating in this activity, participants will be able to:
-
Identify emerging concepts in diagnosis of neuropathological disorders, including developing understanding of non-classical pathology and the role of CSF biomarkers to diagnose various disorders.
-
Describe the application of new technologies and therapeutics in the treatment of cancer.
-
Identify several new clinical applications of emerging technology to address unmet clinical needs.
Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the College of American Pathologists (CAP) and Association of Clinical Scientists. The College of American Pathologists is accredited by the ACCME to provide continuing medical education for physicians.
Accredited CE (CME) Designation
The CAP designates this live educational activity for a maximum of 15.5 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
The content of this accredit CE (CME) activity does not necessarily reflect the view or policies of the College of American Pathologists.
Disclosure Information
Below you will find the financial disclosure relationships for anyone who was able to affect the content of this educational activity.
The CAP mitigates all the relevant financial relationships listed for these individuals.
The following speakers/planners have no financial relationships to disclose:
Christopher Marquez, MDNina Tatevian, MD, PhD
Charles D. Hawker, PhD, MBA
Dennis W. Dickson, MD
Tania Gendron, PhD
C. Burcin Taner, MD
Linnea M. Baudhuin, PhD
Fadi E. Salem, MD
Chris J. Beltran, PhD
Shane A. Shapiro, MD
John Copland, PhD
Ravinder Singh, PhD
Zeynettin Akkus, PhD
Nilufer Ertekin-Taner, MD, PhD
Anthony D. Maus, PhD
Alexander C. Mackinnon, MD, PhD
Jessica Claus, MD
Shuko Harada, MD
Amy Theriault, DO
Rita Hayes, MD
M. John Hicks, MD, DDS, MS, PhD
Falone Amoa, MD, MS
George G. Chen, MD, PhD
Miguel Carabano, MD
Bushra Al-Tarawneh, MD
Faisal Bukeirat, MD
Mustafa Barbhuiya, PhD
Benjamin Andress, PhD
Hunter Miller, PhD
The following speakers/planners have the following financial relationships to disclose:
Jonathan B. Hoyne, PhDDanaher/Stockholder
Melissa E. Murray, PhD
Eli Lilly/ Researcher/ grant
Amitava Dasgupta, PhD
Beckman Coulter/Research grant
Jorge M. Mallea, MD
Lung Biotechnology. Lung BioEngineering and Unithed Therapeutics Corporate/Consulting for all three
Jane J. Hata, PhD
Cognex Corp/Grant/Research support
Seegene, Inc., speaker (relationship ended)
Bryan Dangott, MD
Philips Digital Pathology, consultant
Sectra Scientific Advisory Board (relationship ended)
Sikander Ailawadhi, MD – faculty
GSK/Consultant and research funding to institution
BMS/Consultant and research funding to institution
Sanofi/Consultant and research funding to institution
Janssen/Consultant and research funding to institution
Cellectar/Consultant and research funding to institution
Ascentage/Research funding to institution
Beigene/Consultant
Takeda/Consultant
Regeneron/Consultant
Pfizer/Consultant
Joshua Bornhorst, PhD
ThermoFisher/speaker
Emily Ryan, PhD
Sysmex America/Speaker
Magali Fontaine, MD, PhD
Cerus/PI for Pipe study on pathogen treated platelets
FDA-PR for a RBC study on the effect of pathogen activation
Hemaquebec/Board Member
Best Collective/Scientific Member
AABB/Board Member
Rohan M. Goswami, MD
Abiomed/Honoraria and fees
Christopher Crutchfield, PhD
Beckman Coulter/Consultant
The following In-Kind Support has been received for this activity:
None
The following Commercial Support has been received for this activity:
None